Microglial phenotypes in Parkinson's disease and animal models of the disease. - Wikidata - awgldk - TriplyDB

Microglial phenotypes in Parkinson's disease and animal models of the disease.

Microglial phenotypes in Parkinson's disease and animal models of the disease.

http://www.wikidata.org/entity/Q38815779

about

P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease Herpes zoster correlates with increased risk of Parkinson's disease in older people: A population-based cohort study in Taiwan.Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging.Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide.The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Outdoor Ambient Air Pollution and Neurodegenerative Diseases: the Neuroinflammation Hypothesis.Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia.Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system.Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization.Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease.Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson's Disease Rat Model Through AKT/GSK3β Signaling Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention

P2860

Q33718454-D4361795-3218-4E40-817B-D0D95D97AF92 Q33740654-307C69D9-C9A9-4C39-86A7-E5F9F44BC062 Q37656277-91EDB672-5B74-45F0-A52E-86E5AE54EA9D Q37729235-50A285B1-2562-4C2F-B4EB-298EF09881B7 Q38556918-FF3932C5-478A-4B90-93EE-A01C6BFFE06A Q38617000-F786B99A-7A68-4D9F-BF82-C49C16ED1C83 Q38670012-235DEDD7-B56D-411B-96D7-98B20F866BBF Q39012371-C2158F3B-A00C-410C-BD02-87A244943DD4 Q39263834-66E82990-45A8-45DD-BD9F-A5B7FC0E8730 Q39327711-8BC51A9A-1741-4DA8-92F5-EBE7DE654119 Q42512130-4686FFB6-A60F-45E3-AD15-E1D27ED682FF Q43721606-404AF282-C963-4890-A5A0-EDE04B555278 Q47108252-09D3AE90-AE5A-466F-9A49-BD7B9FC52856 Q47548797-4F114E64-5A92-44D5-8EEE-A72A41B361E7 Q48129166-8BE72ED6-B73A-45F9-B2DF-B1DABD32C275 Q51182174-4E702931-BD27-475A-A816-47C6924A338D Q52640400-368D7A34-EE6A-427A-A4A9-BFF4F172133F Q54942358-6A3A550B-8CEC-4D44-846F-00E665A74B79 Q54960390-BE99B63C-FEBE-43A1-ADCE-760692D556DD Q57490914-F50A0239-9264-44E6-B71E-2E001DF25FA4 Q58614424-01EA095A-6EC7-4245-A040-A3AF4EF2F9C9 Q58799080-979C6891-B943-4423-9B4E-123E52FA8621

P2860

Microglial phenotypes in Parkinson's disease and animal models of the disease.

http://www.wikidata.org/entity/Q38815779

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Microglial phenotypes in Parkinson's disease and animal models of the disease.

@en

type

label

Microglial phenotypes in Parkinson's disease and animal models of the disease.

@en

prefLabel

Microglial phenotypes in Parkinson's disease and animal models of the disease.

@en

P1433

Q38815779-0B89FF45-C6EE-4F00-BEDD-74CAC0840056

P1476

Q38815779-7284165B-B8F2-4DE8-9968-ED93FCB34644

P2093

Q38815779-2585A347-6BE3-4C89-A629-07E2F56B7006

Q38815779-65F3B002-A807-4DD9-9A94-BFCC8CDE8C4F

Q38815779-BF189687-89A0-47D7-930F-F4B027D5FEFC

P2860

Q38815779-004D15F6-D650-491D-BD77-928D70AE953E

Q38815779-00F456F2-67DF-4AB6-9A97-DE87FEFBD6BF

Q38815779-02DC4862-7B36-4548-BFA4-6D2EE3FFD8DC

Q38815779-0410C669-E305-4997-A424-1EAA7973ED9C

Q38815779-0530E25A-7976-4B27-95A7-DBD1BAED706D

Q38815779-064092C9-4516-4C21-86DC-EF9C1C1D72A1

Q38815779-073D12D8-11E0-4835-87DA-FDB7CF9710EF

Q38815779-076DD4BD-E3AA-4CF5-8B8A-1DB5C3781B0A

Q38815779-097CD29E-9501-40C9-9991-BAB91958EF79

Q38815779-0B2C8B7A-583D-4724-BFC1-25E55B8B25A8

P304

Q38815779-CA472540-FB25-43FA-A449-1082CD54E922

P31

Q38815779-63FC99FC-E441-4283-BC96-0B8382C485CE

P356

Q38815779-5D923AF8-1C87-44B1-8513-099CBC45A307

P478

Q38815779-F1ED714F-3148-4BA7-A596-219E18FB5933

P50

Q38815779-CB2C8AE3-B5C7-4BA7-A241-59B597E3EF5F

P577

Q38815779-B43629B1-533F-428F-85DB-4A4C47DB3EE2

P698

Q38815779-5CFE7562-6739-4BE1-AE95-49ED0A326FBF

P921

Q38815779-19B7F36E-2A10-4911-B8FA-34E45D846E8C

P932

Q38815779-7993808E-5348-4E77-9FAD-8CF567248635

P356

J.PNEUROBIO.2016.04.006

P1433

Progress in Neurobiology

P1476

Microglial phenotypes in Parkinson's disease and animal models of the disease.

@en

P2093

Anna R Carta

http://www.w3.org/2001/XMLSchema#string

Giovanna Mulas

http://www.w3.org/2001/XMLSchema#string

Valerie Joers

http://www.w3.org/2001/XMLSchema#string

P2860

Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II

Use of ibuprofen and risk of Parkinson disease

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

P304

57-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PNEUROBIO.2016.04.006

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P50

Malú Gámez Tansey

P577

2016-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27107797

http://www.w3.org/2001/XMLSchema#string

P921

P932

5073045

http://www.w3.org/2001/XMLSchema#string